Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-8554 (Elismetrep) in painful diabetic peripheral neuropathy
NCT05123196Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma
- Start
- Nov 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of elismetrep in diabetic peripheral neuropathy (DPN), sponsored by Mitsubishi Tanabe Pharma. Started Nov 2021; status: completed.
02
Drugs
elismetrep
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT05123196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05123196.